586 related articles for article (PubMed ID: 14696471)
1. Association of HCV and HBV markers in Spanish HIV-seropositive patients in relation to risk practices.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Carballo E; Barrio E
Hepatogastroenterology; 2003; 50(54):2093-7. PubMed ID: 14696471
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of occult hepatitis B & C in HIV patients infected through sexual transmission.
Rai RR; Mathur A; Mathur D; Udawat HP; Nepalia S; Nijhawan S; Mathur A
Trop Gastroenterol; 2007; 28(1):19-23. PubMed ID: 17896605
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, patterns, and course of past hepatitis B virus infection in intravenous drug users with HIV-1 infection.
Rodríguez-Méndez ML; González-Quintela A; Aguilera A; Barrio E
Am J Gastroenterol; 2000 May; 95(5):1316-22. PubMed ID: 10811346
[TBL] [Abstract][Full Text] [Related]
4. Correlates of HIV, HBV, and HCV infections in a prison inmate population: results from a multicentre study in Italy.
Babudieri S; Longo B; Sarmati L; Starnini G; Dori L; Suligoi B; Carbonara S; Monarca R; Quercia G; Florenzano G; Novati S; Sardu A; Iovinella V; Casti A; Romano A; Uccella I; Maida I; Brunetti B; Mura MS; Andreoni M; Rezza G
J Med Virol; 2005 Jul; 76(3):311-7. PubMed ID: 15902712
[TBL] [Abstract][Full Text] [Related]
5. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of antibodies against hepatitis C virus and hepatitis B coinfection in healthy population in Bulgaria. A seroepidemiological study.
Atanasova MV; Haydouchka IA; Zlatev SP; Stoilova YD; Iliev YT; Mateva NG
Minerva Gastroenterol Dietol; 2004 Mar; 50(1):89-96. PubMed ID: 15719010
[TBL] [Abstract][Full Text] [Related]
7. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy.
Guadagnino V; Zimatore G; Izzi A; Caroleo B; Rocca A; Montesano F; Costa C; Masciari R; Naso E; Biselli R
J Clin Lab Immunol; 1995; 47(1):1-9. PubMed ID: 8735431
[TBL] [Abstract][Full Text] [Related]
8. HIV, hepatitis C virus, and hepatitis B virus co-infections among injecting drug users in Tehran, Iran.
Rahimi-Movaghar A; Razaghi EM; Sahimi-Izadian E; Amin-Esmaeili M
Int J Infect Dis; 2010 Jan; 14(1):e28-33. PubMed ID: 19464218
[TBL] [Abstract][Full Text] [Related]
9. Markers and risk factors for HCV, HBV and HIV in a network of injecting drug users in Melbourne, Australia.
Miller ER; Hellard ME; Bowden S; Bharadwaj M; Aitken CK
J Infect; 2009 May; 58(5):375-82. PubMed ID: 19328555
[TBL] [Abstract][Full Text] [Related]
10. [Chronic hepatitis B and C in HIV-infected patients].
Opravil M; Hunziker R; Lüthy R; Grob PJ
Dtsch Med Wochenschr; 1998 Jun; 123(24):753-60. PubMed ID: 9672477
[TBL] [Abstract][Full Text] [Related]
11. Frequency of isolated hepatitis B core antibody in HIV-hepatitis C virus co-infected individuals.
Ramezani A; Mohraz M; Aghakhani A; Banifazl M; Eslamifar A; Khadem-Sadegh A; Velayati AA
Int J STD AIDS; 2009 May; 20(5):336-8. PubMed ID: 19386971
[TBL] [Abstract][Full Text] [Related]
12. Intrafamilial transmission of hepatitis B and C viruses in an Italian local health district.
Del Corno G; Civardi E
Ann Ig; 2006; 18(4):287-95. PubMed ID: 17063627
[TBL] [Abstract][Full Text] [Related]
13. Anti-hepatits B core antigen testing, viral markers, and occult hepatitis B virus infection in Pakistani blood donors: implications for transfusion practice.
Bhatti FA; Ullah Z; Salamat N; Ayub M; Ghani E
Transfusion; 2007 Jan; 47(1):74-9. PubMed ID: 17207233
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of occult hepatitis B in hepatitis C-infected Egyptian children with haematological disorders and malignancies.
Said ZN; El-Sayed MH; El-Bishbishi IA; El-Fouhil DF; Abdel-Rheem SE; El-Abedin MZ; Salama II
Liver Int; 2009 Apr; 29(4):518-24. PubMed ID: 19192168
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C infection among intravenous drug users attending therapy programs in Cyprus.
Demetriou VL; van de Vijver DA; Hezka J; Kostrikis LG; ; Kostrikis LG
J Med Virol; 2010 Feb; 82(2):263-70. PubMed ID: 20029809
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of chronic hepatitis B virus infection among taiwanese human immunodeficiency virus type 1-positive persons in the era of nationwide hepatitis B vaccination.
Sun HY; Ko WC; Tsai JJ; Lee HC; Liu CE; Wong WW; Su SC; Ho MW; Cheng SH; Yang CH; Lin YH; Miao WJ; Sheng WH; Hung CC
Am J Gastroenterol; 2009 Apr; 104(4):877-84. PubMed ID: 19259078
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of hepatitis B virus and hepatitis C virus in patients with human immunodeficiency virus infection in Central China.
Chen X; He JM; Ding LS; Zhang GQ; Zou XB; Zheng J
Arch Virol; 2013 Sep; 158(9):1889-94. PubMed ID: 23553454
[TBL] [Abstract][Full Text] [Related]
19. Risk behaviors and antibody hepatitis B and C prevalence among injecting drug users in south-western Sydney, Australia.
Maher L; Chant K; Jalaludin B; Sargent P
J Gastroenterol Hepatol; 2004 Oct; 19(10):1114-20. PubMed ID: 15377287
[TBL] [Abstract][Full Text] [Related]
20. [Seroprevalence of delta virus and hepatitis C virus in patients with chronic infection with hepatitis B virus].
de Miguel J; Collazos J; Mayo J; López de Goicoechea MJ; Echániz C; Mendarte U
Rev Clin Esp; 1994 Oct; 194(10):897-900. PubMed ID: 7800870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
